Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Remote Monitoring of Cardiac Mechanics in Heart Failure Patients

Seismocardiographic Monitoring in Heart Failure

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Heart failure is a severe heart disease, where the heart's ability to pump blood is unsatisfactory. The consequence is a high risk of hospitalization and death. Heart failure is treated with medicine which relieves symptoms and slows down the disease progression. This medical treatment needs routine adjustment, but in many cases, this adjustment is not done timely, which results in life treating conditions where the patients need acute hospitalization. Remote health monitoring of HF patients has the potential to ensure timely adjustment. However, only sensors placed inside the blood vessels of the lung, have been shown effective. The disadvantage is that the placement of the sensor requires surgery. This makes the method costly and poses a risk for the patient. The aim of the current project is to develop a small intelligent patch, which can measure the heart's function from the outside of the body. The method will be low-cost, simple to use and will not pose a risk to the patient.

Who May Be Eligible (Plain English)

Who May Qualify: - NYHA Class II or higher - 18-90 years old Who Should NOT Join This Trial: - Pregnancy - Drug addiction defined as the use of cannabis, opioids, or other drugs - Mechanical heart valves - In dialysis - Not possible to obtain clinical echocardiography of sufficient quality - Lack of ability to coorperate Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * NYHA Class II or higher * 18-90 years old Exclusion Criteria: * Pregnancy * Drug addiction defined as the use of cannabis, opioids, or other drugs * Mechanical heart valves * In dialysis * Not possible to obtain clinical echocardiography of sufficient quality * Lack of ability to coorperate

Treatments Being Tested

OTHER

Continuous monitroing

Continuous monitoring for 30 days with a small combined SCG and 1-lead ECG sensor

Locations (2)

Aalborg University Hospital
Aalborg, Denmark, Denmark
Copenhagen University Hospital Herlev
Herlev, Denmark, Denmark